Legato Capital Management »

Deciphera Pharmaceuticals shares owned by Legato Capital Management

Quarter-by-quarter ownership of Deciphera Pharmaceuticals (DCPH) shares owned by Legato Capital Management from 13F filings

Historical chart of Legato Capital Management investment in Deciphera Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Deciphera Pharmaceuticals held by Legato Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Deciphera Pharmaceuticals by Legato Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $828k 53k 15.73

More positions owned by Legato Capital Management

Broadcom (AVGO)
Apple (AAPL)
UFP Technologies (UFPT)
Ies Hldgs (IESC)
Microsoft Corporation (MSFT)
Stryker Corporation (SYK)
Accenture (ACN)
ePlus (PLUS)
Bgc Group Inc Cl A (BGC)
Visa (V)
Merck & Co (MRK)
Agilysys (AGYS)
Argan (AGX)
Stonex Group (SNEX)
Alphabet Inc Class A cs (GOOGL)

View all positions for Legato Capital Management

Top funds holding Deciphera Pharmaceuticals

Deerfield Management Company
Redmile Group
Vanguard Group
Goldman Sachs Group
Dimensional Fund Advisors
Braidwell
Frazier Life Sciences Management
Assenagon Asset Management
Emerald Advisers
Millennium Management
Emerald Mutual Fund Advisers, Trust
Charles Schwab Investment Management
Deutsche Bank Aktiengesellschaft
Two Sigma Advisers
Jacobs Levy Equity Management

View all funds holding Deciphera Pharmaceuticals